Background on HLA-B27
The HLA-B27 allele is part of the human leukocyte antigen (HLA) system, located within the major histocompatibility complex (MHC) on chromosome 6. HLA molecules play a central role in antigen presentation and immune regulation. Specific variants of the HLA-B gene, particularly HLA-B27, are strongly associated with a group of autoimmune inflammatory diseases collectively known as spondyloarthropathies.
These conditions include ankylosing spondylitis, reactive arthritis, and related disorders affecting the spine and peripheral joints. The presence of the HLA-B27 allele is a well-established genetic risk factor and is widely studied in relation to disease susceptibility, progression, and immune system dysregulation. In addition, HLA-B27 has been investigated in infectious disease research, where it may influence immune response and clinical outcome.
Reliable detection of HLA-B27 is therefore important in molecular research focused on immune function, genetic predisposition, and biomarker identification.
Kit Description
The HLA-B27™ Detection Kit is designed for the qualitative detection of the HLA-B27 allele using real-time PCR technology. The assay targets polymorphic regions within exon 2 of the HLA-B gene, enabling specific amplification and detection of HLA-B27 variants. The workflow is streamlined into a single assay, reducing hands-on time and minimizing variability between runs.
The kit is suitable for laboratories requiring reproducible and sensitive detection of HLA-B27, and can be integrated into standard molecular biology workflows.
Internal Control and Assay Reliability
An endogenous β-globin gene is included as an internal control to verify DNA quality and confirm correct assay performance. This control ensures that negative results are not due to poor DNA integrity or PCR inhibition, supporting accurate interpretation of results.
The inclusion of this control contributes to consistent assay performance across different sample types and experimental conditions.
Reagents and Performance
All components of the HLA-B27™ Detection Kit are manufactured under strict quality standards to ensure reproducibility and reliability. The assay is optimized for high specificity and sensitivity, allowing accurate detection of HLA-B27 variants across a range of sample inputs.
The kit requires only a low amount of genomic DNA and is compatible with DNA extracted from peripheral blood or saliva. Validation has been performed using reference materials and characterized samples, confirming robust performance in molecular research settings.
Research Applications
Detection of the HLA-B27 allele supports research into autoimmune disease mechanisms, particularly in spondyloarthropathies. Identification of this genetic marker enables studies on disease association, population genetics, and immune system function.
In addition, HLA-B27 status can be used in research investigating host-pathogen interactions and immune response variability. Reliable genotyping supports correlation studies between genetic background and disease phenotype, contributing to a better understanding of immune-mediated disorders.
Summary
The HLA-B27™ Detection Kit provides a reliable and reproducible solution for the detection of the HLA-B27 allele. Its real-time PCR-based workflow, internal control, and optimized reagents ensure accurate results with minimal procedural complexity.
Designed for integration into standard laboratory workflows, the kit supports molecular research into genetic predisposition, immune function, and autoimmune disease mechanisms.
